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Summary
Background The burden of stroke on health systems in low-income and middle-income countries is increasing. 
However, high-quality data for modiﬁ able stroke risk factors in sub-Saharan Africa are scarce, with no community-
based, case-control studies previously published. We aimed to identify risk factors for stroke in an incident population 
from rural and urban Tanzania.
Methods Stroke cases from urban Dar-es-Salaam and the rural Hai district were recruited in a wider study of stroke 
incidence between June 15, 2003, and June 15, 2006. We included cases with ﬁ rst-ever and recurrent stroke. 
Community-acquired controls recruited from the background census populations of the two study regions were 
matched with cases for age and sex and were interviewed and assessed. Data relating to medical and social history 
were recorded and blood samples taken.
Findings We included 200 stroke cases (69 from Dar-es-Salaam and 131 from Hai) and 398 controls (138 from Dar-es-
Salaam and 260 from Hai). Risk factors were similar at both sites, with previous cardiac event (odds ratio [OR] 7·39, 
95% CI 2·42–22·53; p<0·0001), HIV infection (5·61, 2·41–13·09; p<0·0001), a high ratio of total cholesterol to HDL 
cholesterol (4·54, 2·49–8·28; p<0·0001), smoking (2·72, 1·49–4·96; p=0·001), and hypertension (2·14, 1·09–4·17; 
p=0·026) identiﬁ ed as signiﬁ cant independent risk factors for stroke. In Hai, additional risk factors of diabetes (4·04, 
1·29–12·64) and low HDL cholesterol (9·84, 4·06–23·84) were also signiﬁ cant.
Interpretation We have identiﬁ ed many of the risk factors for stroke already reported for other world regions. HIV 
status was an independent risk factor for stroke within an antiretroviral-naive population. Clinicians should be aware 
of the increased risk of stroke in people with HIV, even in the absence of antiretroviral treatment.
Funding The Wellcome Trust.
Introduction
The burden of stroke in sub-Saharan Africa is in creas-
ing.1,2 Because prevention is likely to be the most eﬀ ective 
way to reduce this burden, identiﬁ cation and 
quantiﬁ cation of stroke risk factors, particularly those 
that are modiﬁ able, is of interest. The international, 
multicentre, INTERSTROKE study3 of 3000 cases and 
3000 controls from 22 countries identiﬁ ed ten risk factors 
that accounted for 90% of the risk of stroke in those 
countries. These risk factors were history of hypertension, 
current smoking, high waist-to-hip ratio, poor diet, 
absence of regular physical activity, diabetes mellitus, 
high alcohol intake, psychosocial stress and depression, 
cardiac causes, and apolipoprotein ratio. The study 
included four countries in sub-Saharan Africa: South 
Africa, Nigeria, Mozambique, and Uganda. History of 
hypertension or blood pressure higher than 
160/90 mm Hg was the biggest risk factor overall and 
had the highest odds ratio (OR) in the 323 African cases 
(3·89 overall [99% CI 3·33–4·54] and 4·96 [99% CI 
3·11–7·91] in African cases). However, all included 
patients with stroke had to present at hospital within 
5 days of symptom onset and undergo a CT or MRI scan 
of the brain within 1 week. Such imaging facilities are 
unlikely to be widely available or aﬀ ordable to patients in 
sub-Saharan Africa, and those who undergo CT scan are 
unlikely to be representative of the wider population of 
patients with incident stroke. We have previously shown 
that only a few patients with stroke present to hospital in 
sub-Saharan Africa, and, in many of the most severe 
cases, patients die soon after onset.4,5
Several studies from high-income countries have 
shown that black and white populations from the same 
region have diﬀ erent risk-factor proﬁ les for stroke, with 
hypertension and diabetes mellitus being much more 
prevalent risk factors in black populations, and cardiac 
abnormalities and smoking more prevalent in white 
populations.6,7 However, data from sub-Saharan Africa 
are scarce. Investigators of the Berlin–Ibadan stroke 
study8 compared risk factors for hospital admissions for 
stroke in Berlin, Germany, with those in Ibadan, Nigeria. 
Hypertension was signiﬁ cantly more common in the 
Ibadan cohort, whereas smoking, high cholesterol, 
atherosclerosis, and cardiac abnormalities were more 
common in patients from Berlin. Amu and colleagues9 
assessed 80 patients with stroke and 80 controls recruited 
from hospital admissions in Nigeria. Hypertension, 
diabetes mellitus, atrial ﬁ brillation, obesity, physical 
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inactivity, and smoking were signiﬁ cant risk factors for 
stroke, whereas concentrations of serum cholesterol, 
alcohol consumption, and dietary habits had no increased 
odds of stroke for cases versus controls. These results are 
similar to those of Danesi and colleagues10 in a previous 
hospital-based study in Lagos, Nigeria; however, ﬁ ndings 
from that study showed raised serum cholesterol and low 
socioeconomic class as additional risk factors.
We are not aware of any previous community-based, 
case-control studies of risk factors for stroke in sub-
Saharan Africa. We did a case-control study to investigate 
the role of potential risk factors for stroke in an incident 
group of patients with stroke from an urban and rural 
region of Tanzania.
Methods
Study design and participants
Participants in the present study were part of a wider 
study of stroke incidence4 in which patients were recruited 
from June 15, 2003, to June 15, 2006. The study was done 
at two sites: the rural Hai district in northern Tanzania, 
and urban Dar-es-Salaam, Tanzania’s largest city and its 
commercial capital. The Hai district site is a region of 
52 villages, with an economy based on subsistence 
farming, with cash crops such as coﬀ ee also grown. The 
Dar-es-Salaam site was chosen to be representative of the 
socioeconomic proﬁ le and living conditions within the 
city, with a mixture of planned and unplanned housing. 
Both sites were set up in the 1990s as Demographic 
Surveillance Sites (DSS) for use in the Adult Morbidity 
and Mortality Project (AMMP) for epidemiological 
monitoring by the Tanzanian government. Key results 
from the AMMP have been previously published.11
The wider incidence study used two methods of case 
ascertainment: the Tanzanian Stroke Incidence Project 
(TSIP) and verbal autopsy.4 Our study here is based on 
consecutive cases recruited via TSIP who survived long 
enough to undergo assessment. We used the standard 
WHO deﬁ nition of stroke and included patients with 
ﬁ rst-ever and recurrent stroke. To maximise recruitment 
and reduce selection bias, the TSIP study was extensively 
advertised within the study regions and paid for 
participants to attend hospital and receive treatment for 
the ﬁ rst year after stroke. A programme of awareness 
raising via census enumerators, local health-care 
workers, and community leaders was also done. Any 
possible cases of incident stroke were notiﬁ ed, via the 
enumerators, to clinical oﬃ  cer supervisors for the study 
as soon as possible so they could be assessed in their own 
homes. This prompt notiﬁ cation was particularly 
important for those making a rapid recovery from stroke. 
Individuals thought to have had a stroke were transferred 
to hospital for further investigation led by a local 
physician (EA or AJ).
Controls were recruited from the background census 
population of the Hai and Dar-es-Salaam DSS. They were 
identiﬁ ed from the census list and frequency matched to 
cases for age (plus or minus 3 years) and sex. A list of 
possible controls was produced with a random number 
generator. The controls were randomly assigned a 
preference and visited in order. If a control was 
unavailable or refused to participate the next person on 
the list was visited and so forth, until suﬃ  cient controls 
had been recruited. All participants were given an 
identiﬁ cation number to ensure that testing of blood 
samples was done anonymously.
Ethics approval for the TSIP study was obtained from 
the National Institute of Medical Research, Dar-es-
Salaam, and from the Newcastle and North Tyneside Joint 
Ethics Committee, UK. Approval included blood sampling 
and anonymous HIV testing. Each participant provided 
signed informed consent. We obtained a thumbprint for 
participants who could not read or write, and the purpose 
and implications of the study were verbally explained. 
When patients were unable to provide consent, written 
assent was obtained from a close relative.
Measurement of risk factors
Cases and controls were interviewed in as similar a way as 
possible by members of the study team (supervised by EA 
or AJ) who had received speciﬁ c training in the data 
collection process. The same proforma was used, although 
sections relating to the stroke itself were not completed for 
controls. Patients were interviewed in hospital and controls 
in their nearest health facility or at home. Demographic 
information, social history, and past medical history were 
recorded. Collection of accurate information about age can 
be diﬃ  cult in sub-Saharan Africa; thus, age was calculated 
from birth year and conﬁ rmed with memory prompts 
when the year of birth was in doubt.12 All participants 
underwent a medical assessment and examination. Post-
stroke impairment was assessed with the modiﬁ ed Rankin 
scale.13 Blood pressure was recorded at least 7 days after 
stroke to allow for the fact that blood pressure can rise 
during the ﬁ rst few days after stroke. Three measurements 
were taken and the average of the second and third 
measurement used.14 A cutoﬀ  of greater than 160 mm Hg 
systolic or 90 mm Hg diastolic blood pressure, a history of 
hypertension, or taking of antihypertensive drugs before 
stroke were regarded as indicators of hypertension.3 
Smoking and drinking were categorised in a similar way to 
the INTERSTROKE study.3 Current smokers were patients 
who had smoked tobacco in the past 12 months, including 
those who had quit in that period, and former smokers 
were those who had smoked, but not in the past year. 
Drinkers were categorised as never, former, moderate 
(<4 days per week) and heavy (≥4 days per week). Non-
fasting blood samples were taken from those who 
consented. The collected blood samples were centrifuged, 
frozen, and transported back to the UK where they were 
analysed at North Tyneside General Hospital with an 
automated biochemical analyser. In accordance with the 
recommendations of the US National Cholesterol 
Education Program,15 high serum total cholesterol was 
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deﬁ ned as 5·18 mmol/L or greater, and low concentrations 
of HDL cholesterol as less than 1·04 mmol/L. Although no 
universally accepted cutoﬀ  exists, a high ratio of total 
cholesterol to HDL cholesterol was deﬁ ned as 5·0 or more.
Infection with HIV was tested with an ARCHITECT 
HIV Ag/Ab Combo assay (Abbott Laboratories, 
Wiesbaden, Germany), which is a chemiluminescent 
microparticle immunoassay for the simultaneous 
qualitative detection of HIV p24 antigen and antibodies to 
HIV type 1 (HIV-1 group M and group O) or type 2 (HIV-2), 
or both. An ARCHITECT HIV Ag/Ab Combo reactive 
result does not distinguish between the detection of HIV-1 
p24 antigen, HIV-1 antibody, or HIV-2 antibody. If the ratio 
of sample chemiluminescent to the cutoﬀ  (S:CO) values is 
1 or greater then the sample was considered to be reactive. 
Each sample that tested positive was retested to check the 
result. CT head scan was done in stroke cases who 
survived long enough to undergo examination.16 Findings 
of ischaemia, haemorrhagic infarct, or no evidence of 
stroke were classiﬁ ed as ischaemic stroke.
Statistical analysis
In view of the uncertainty in determination of age, pair 
matching was not regarded as an appropriate technique; 
therefore, we used frequency matching for age and sex to 
obtain a similar distribution for cases and controls. We 
analysed data as for an unmatched case-control study. 
The data were quantitative and obtained at a nominal, 
ordinal, interval, and ratio level. Data were analysed with 
SPSS (version 18). CIs were calculated for odds ratios 
(OR; categorical data) and for diﬀ erences between means 
(continuous, normally distributed data). We used 
univariate logistic regression modelling to identify 
signiﬁ cant predictors of caseness before multivariable 
analysis. The known stroke risk factors of hypertension, 
smoking status, alcohol consumption, presence of 
diabetes mellitus, having had a previous stroke or 
transient ischaemic attack, and a high ratio of total 
cholesterol to HDL cholesterol were forced into the 
multivariable model and other possible predictor 
variables investigated via stepwise methods. We used 
two-tailed tests throughout. Missing values were treated 
as being missing completely at random.
Role of the funding source
The sponsors of this study had no role in study design, 
data collection, data analysis, data interpretation. or writing 
of the report, or in the decision to submit for publication. 
The corresponding author had full access to all the data in 
the study and had ﬁ nal responsibility for the decision to 
submit for publication.
Results
201 strokes were identiﬁ ed by the TSIP system (132 in 
Hai and 69 in Dar-es-Salaam). One case of subarachnoid 
haemorrhage in Hai was excluded from the present 
study because of the diﬀ erent cause of this stroke type. 
Cases were matched to 138 (1:2) controls in Dar-es-
Salaam and 260 (1:1·98) controls in Hai. Table 1 shows 
the baseline characteristics of cases and controls at each 
site. We noted no signiﬁ cant diﬀ erence between cases 
Cases Controls Diﬀ erence or OR (95% CI)
Dar-es-Salaam
n 69 138 ··
Age (years) 61·7 (15·0) 61·4 (13·1) Diﬀ erence 0·3 (–3·9 to 4·5)
Men 38 (55%) 74 (54%) OR 1·06 (0·59 to 1·89)
Tribe
Zaramo 19 (28%) 23 (17%) ··
Ndengereko 10 (14%) 33 (24%) ··
Other 40 (58%) 82 (59) ··
Formal education OR for no formal education versus 
formal education 1·21 (0·63 to 2·33)
None or illiterate 20 (29%) 39 (28%) ··
Primary education (≤8 years) 30 (43%) 63 (46%) ··
Secondary school 3 (4%) 9 (7%) ··
Tertiary education 8 (12%) 25 (18%) ··
Missing value 8 (12%) 2 (1%) ··
Pre-stroke modiﬁ ed Rankin scale score*†
0–1 42 (61%) ·· ··
2–3 14 (20%) ·· ··
4–5 4 (6%) ·· ··
Stroke type by CT scan‡
Haemorrhage 3 (4%) ·· ··
Infarct 14 (20%) ·· ··
Hai
n 131 260 ··
Age (years) 68·8 (14·8) 69·4 (14·6) Diﬀ erence 0·6 (–2·5 to 3·7)
Men 69 (53%) 140 (54%) OR 1·05 (0·69 to 1·60)
Tribe
Zaramo 11 (8%) 3 (1%) ··
Chagga 110 (84%) 240 (92%) ··
Other 10 (8%) 17 (7%) ··
Formal education OR for no formal education versus 
formal education 1·26 (0·77 to 2·06)
None or illiterate 34 (26%) 57 (22%) ··
Primary education (≤8 years) 83 (63%) 174 (67%) ··
Secondary school 6 (5%) 14 (5%) ··
Tertiary education 6 (5%) 13 (7%) ··
Missing value 2 (2%) 2 (<1) ··
Pre-stroke modiﬁ ed Rankin scale score*§
0–1 95 (73%) ·· ··
2–3 6 (5%) ·· ··
4–5 3 (2%) ·· ··
Stroke type by CT scan¶
Haemorrhage 11 (8%) ·· ··
Infarct 52 (39%) ·· ··
Data are mean (SD) or n (%), unless otherwise indicated. OR=odds ratio. *0=no symptoms, 1=minor symptoms not 
interfering with lifestyle, 2=some restriction of lifestyle, 3=signiﬁ cant restriction in lifestyle or prevention of 
independent existence, or both, 4=symptoms clearly prevent independent existence, 5=totally dependent requiring 
constant attention, 6=deceased.13 †Nine missing values. ‡52 missing values. §27 missing values. ¶68 missing values.
Table 1: Baseline characteristics
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and controls in age, sex, or education. We attempted to 
interview cases as soon as possible after incident stroke, 
but a few were not identiﬁ ed as having had a stroke until 
visited by a health-care worker or key informant some 
months later. Nevertheless, 114 (57%) cases were seen 
within 28 days of stroke, only 17 (8%) cases were 
interviewed at more than 6 months after stroke. The 
median time from incident stroke to assessment 
interview was 19 days (range 0–252). For the groups who 
were seen at 28 days or more after stroke and those seen 
at less than 28 days, we noted no signiﬁ cant diﬀ erence in 
rates of hypertension (OR 1·82, 95% CI 0·75–4·42) or 
ratio of total cholesterol to HDL cholesterol (1·99, 
0·91–4·36).
Some cases and controls refused to have blood samples 
taken or blood samples could not be taken for other 
reasons—eg, the participant had died before a blood 
sample could be obtained or were unavailable at the time 
of testing. However, for the entire study population of 
598 individuals, when we made comparisons between 
the 410 (69%) individuals who did have blood samples 
taken and the 188 (31%) who did not, we noted no 
signiﬁ cant diﬀ erences in age (mean 65·8 [SD 15·2] vs 
68·2 [13·7] years, 95% CI for diﬀ erence –0·1 to 4·8) or 
sex (226 [55%] vs 95 [51%] men, 95% CI for diﬀ erence 
–4·4 to 12·8). In 11 (5%) cases for whom the HIV result 
was borderline positive (S:CO value range 1–9) the 
sample was too insuﬃ  cient to allow a repeat sample. 
However, in all patients for whom the test could be 
repeated, the initial result was conﬁ rmed.
Table 2 shows results of the univariate analysis. The 
ﬁ ndings show that risk factors were similar at both sites, 
with HIV status, hypertension, smoking status, previous 
cardiac event, and a high ratio of total to HDL cholesterol 
level being signiﬁ cantly associated with caseness at both 
sites (table 2). In Hai, additional risk factors of diabetes 
and low HDL cholesterol were also signiﬁ cant (table 2). 
Diabetes was associated with increased risk in 
Dar-es-Salaam, albeit not signiﬁ cantly (table 2). Of 
25 stroke cases with HIV infection, 16 (64%) were men, 
whereas of 77 cases without HIV infection, 39 (51%) were 
men (95% CI for diﬀ erence in proportions –8·5 to 35·2). 
The mean age of stroke cases that had HIV infection was 
63·2 years (SD 16·5) versus 67·4 years (17·6) for cases 
without HIV infection (95% CI –12·0 to 3·6). HIV status 
was not signiﬁ cantly associated with stroke subtype. At 
both sites, of the 56 (9%) participants with a blood result 
and a CT scan within 15 days of stroke, two (15%) of 13 
with HIV had haemorrhagic stroke, and 11 had ischaemic 
stroke. By comparison, ﬁ ve (12%) of 43 without HIV had a 
haemorrhagic stroke and 38 had an ischaemic stroke 
(χ²1=0·129, p=0·720). No participant identiﬁ ed as being 
HIV positive was previously diagnosed; therefore, none 
was receiving antiretroviral therapy.
The risk-factor proﬁ le was similar across both sites; 
therefore, for multivariable analysis, we combined data 
from both sites and constructed a logistic regression 
Cases Controls OR (95% CI)
Dar-es-Salaam
n 69 138 ··
Hypertension 3·33 (1·46–7·57)
Yes 55/63 (87%) 93 (67%) ··
No 8/63 (13%) 45 (33%) ··
Missing value 6 .. ··
Smoking status Non vs former or current 
5·96 (2·96–11·98)
Non-smoker 18/53 (34% ) 95/126 (75%) ··
Former smoker  21/53 (40%) 14/126 (11%) ··
Current 14/53 (26%) 17/126 (14%) ··
Missing value 16 12 ··
Alcohol consumption Never, former or moderate 
vs heavy 0·79 (0·20–3·08)
Former or never 49/62 (79%) 102/132 (77%) ··
Moderate 10/62 (16%) 22/132 (17%) ··
Heavy 3/62 (5%) 8/132 (6%) ··
Missing value 7 6 ··
Diabetes mellitus 2·76 (0·89–8·58)
Yes 7/62 (11) 6/136 (4%) ··
No 55/62 (89%) 130/136 (96%) ··
Missing value 7 2 ··
Atheroma risk factors*† 9/59 (15%) 10/136 (7%) 2·27 (0·87–5·91)
Missing value 10 2 ··
Previous stroke, myocardial infarction, or 
transient ischaemic attack*
4·45 (1·42–13·90)
Yes 9/62 (14%) 5/136 (4%) ··
No 53/62 (86%) 131/136 (96%) ··
Missing value 7 2 ··
Asthma 7/58 (12%) 7/136 (5%) 2·53 (0·84–7·57)
Missing value 7 2 ··
Blood serum samples
High total cholesterol 28/54 (52%) 42/103 (41%) 1·56 (0·81–3·03)
Missing value 15 35 ..
Low HDL cholesterol 42/53 (79%) 66/103 (64%) 2·14 (0·98–4·65)
Missing value 16 35 ..
High ratio of total to HDL cholesterol 
ratio
41/53 (77%) 45/103 (44%) 4·40 (2·08–9·34)
Missing value 16 35 ..
HIV se ropositive 14/30 (47%) 10/58 (17%) 4·20 (1·56–11·30)
Missing value 39 80 ..
Hai
n 131 260 ··
Hypertension 1·80 (1·04–3·10)
Yes 88/109 (81%) 182 (70%) ··
No 21/109 (19%) 78 (30%) ··
Missing value 22 .. ··
Smoking Non vs former or current 
2·69 (1·62–4·49)
Non-smoker 25/109 (23%) 113/254 (44%) ··
Former smoker 67/109 (62%) 78/254 (31%) ··
Current 17/109 (15%) 63/254 (25%) ··
Missing value 22 6 ··
(Continues on next page)
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model (table 3). The analysis was based on data for 
92 cases and 220 controls. High total cholesterol to HDL 
cholesterol ratio, being a current or former smoker, HIV 
infection, hypertension, and a previous cardiac event 
were all independent predictors of stroke; however, we 
recorded no association between stroke and alcohol 
consumption or a diagnosis of diabetes mellitus (table 3). 
The adjusted odds of someone with HIV infection having 
a stroke were more than ﬁ ve times that of someone 
without HIV (table 3).
Discussion
This report is the ﬁ rst published community-based, case-
control study to identify HIV infection as a risk factor for 
stroke with prospective case-ascertainment.17 Our data 
suggest that, aside from this risk factor, the stroke risk-
factor proﬁ le of this east-African population is similar to 
that shown for other world regions.3 Hypertension, 
diabetes, smoking, cholesterol, and previous cardiac 
events have been cited by other investigators as risk 
factors for stroke in sub-Saharan Africa and elsewhere.3,9,10 
Hypertension is extremely common in this population 
and is generally undiagnosed and untreated.18 
Nevertheless, in this resource-poor setting, this disorder 
is one of the most easily treatable risk factors. 
Identiﬁ cation of people with hypertension at a community 
level need not involve expensive equipment or highly 
skilled personnel, and treatment is relatively inexpensive.
Data from our community-based antiretroviral-naive 
cohort suggest that HIV positivity is a signiﬁ cant 
independent risk factor for stroke (panel). Although 
increasing evidence exists for a link between HIV and 
stroke, deﬁ nitive data have been scarce.17,22–25 Research has 
been complicated by the use of antiretroviral therapy to 
treat people with HIV, some forms of which have been 
linked to an increased risk of cardiovascular disease.26 
Even in the absence of medication, although HIV infection 
can be a direct cause of vasculopathy, it is more likely to be 
associated with an increased risk of stroke when combined 
with a secondary infection.23,27 HIV-infected patients with 
stroke are generally thought to have a more varied 
presentation than those without HIV infection.28
Most previous studies of HIV and stroke have used a 
retrospective, exposed and non-exposed cohorts design 
to compare people with and without HIV infection and 
investigate stroke incidence within the groups.24,29 The 
strongest evidence comes from a retrospective, hospital-
based, case-control study done between 1990 and 1994, in 
Atlanta, GA, USA.23 The investigators reviewed post-
stroke hospital admissions in 113 patients aged 
19–44 years and the same number of controls (admissions 
with status asthmaticus) in whom HIV status was 
known. The researchers noted that stroke cases were 
signiﬁ cantly more likely (OR 2·3, 95% CI 1·0–5·3) to be 
HIV positive than were controls, after adjustment for 
confounding variables. However, the generalisability of 
these results to the wider population is limited by the 
Cases Controls OR (95% CI)
(Continued from previous page)
Alcohol Never, former or moderate 
vs heavy 1·53 (0·84–2·77)
Former or never 47/109 (43%) 103/259 (40%) ··
Moderate 41/109 (38%) 121/259 (47%) ··
Heavy 21/109 (19%) 35/259 (13%) ··
Missing value 22 1 ··
Diabetes 4·04 (1·29–12·64)
Yes 8/109 (7%) 5/260 (2%) ··
No 101/109 (93%) 255/260 (98%) ··
Missing value 22 .. ··
Atheroma risk factors*† 1·21 (0·50–2·91)
Yes 8/109 (7%) 16/260 (6%) ··
No 101/109 (93%) 244/260 (94) ··
Missing value 22 ··
Previous stroke, myocardial infarction or 
transient ischaemic attack*
9·14 (3·77–22·14)
Yes 22/109 (20%) 7/260 (3%) ··
No 87/109 (80%) 253/260 (97%) ··
Missing value 22 .. ··
Asthma 3/109 (3%) 11/260 (4%) 0·64 (0·18–2·34)
Missing value 22 .. ··
Blood serum samples
High total cholesterol 26/76 (34%) 60/177 (34%) 1·01 (0·58–1·79)
Missing value 55 83 ··
Low HDL cholesterol 70/76 (92%) 96/177 (54%) 9·84 (4·06–23·84)
Missing value 55 83 ··
High ratio of total to HDL cholesterol 
ratio
52/76 (68%) 67/177 (38%) 3·56 (2·01–6·30)
Missing value 55 83 ··
HIV seropositive 11/72 (15%) 5/174 (3%) 6·10 (2·04–18·26)
Missing value 59 86 ··
Data are n or n/N (%), unless otherwise indicated. OR=odds ratio. *Presence of one or more of these factors was 
recorded as “yes”. †Angina, diabetes, or intermittent claudication.
Table 2: Univariate analysis of stroke risk factors 
OR (95% CI) p value
Previous transient ischaemic attack or stroke 7·39 (2·42–22·53) <0·0001
HIV seropositive 5·61 (2·41–13·09) <0·0001
High ratio of total cholesterol to HDL cholesterol 4·54 (2·49–8·28) <0·0001
Current or former smoker 2·72 (1·49–4·96) 0·001
Hypertension 2·14 (1·09–4·17) 0·026
Diabetes mellitus 1·38 (0·35–5·39) 0·644
Alcohol consumption
Non-drinker* 1 0·700
Former drinker 1·05 (0·43–2·56) 0·916
Moderate drinker 0·96 (0·45–2·02) 0·912
Heavy drinker 1·62 (0·69–3·78) 0·268
Constant† 0·04 <0·0001
Based on data for 92 cases and 220 controls. OR=odds ratio. *Reference category. †The y intercept in a hypothetical 
schematic representation of our model.
Table 3: Multivariable logistic regression models of stroke risk factors
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young age of the patients, the retrospective nature of the 
data examined, and by the hospital setting. Only few data 
are from sub-Saharan Africa, and much of it is descriptive 
in nature.22,30 Patel and colleagues31 recorded no diﬀ erence 
in tests for cardiovascular disease between 293 HIV-
infected and non-infected participants aged 15–44 years 
in KwaZulu-Natal, South Africa. These ﬁ ndings support 
those of a previous study in KwaZulu-Natal by Hoﬀ mann 
and colleagues,32 which showed no increase in rates of 
HIV infection in 1298 stroke cases versus the general 
population.
Our estimate of the prevalence of diabetes and other 
comorbidities could be an underestimate. Data were 
based on self-report, which is particularly unreliable in 
view of low rates of diagnosis. Unfortunately, we were 
unable to obtain reliable data for obesity, psychosocial 
stress, depression, and physical activity or diet. Although 
height and weight were recorded for all controls, many 
cases could not be weighed with the equipment available 
because of post-stroke disability. We were unable to 
assess the eﬀ ect of physical exercise or diet as risk factors 
on stroke. In Hai, most people work as farmers, whereas 
in Dar-es-Salaam, people lead more westernised working 
lifestyles. Opportunities to make active choices about 
diet and exercise are often scarce in both settings. 
We accept that data relating to some risk factors, such as 
tobacco and alcohol consumption, can be somewhat 
subjective. Retrospective recall of events and behaviours 
that preceded the event being investigated is often 
diﬃ  cult and can lead to bias, especially when questions 
are asked about factors that might have some social 
stigma. However, this limitation is one of all case-control 
studies and could only be overcome by collection of 
prospective data from an extremely large community 
cohort.
For several participants we were unable to obtain a 
blood sample. Although this shortcoming was often due 
to early post-stroke mortality, a few individuals were 
unwilling to consent to a blood sample being taken. We 
did our best to increase the number of participants 
willing to consent to blood samples being taken by 
enlisting the help of village elders and village heads. 
Although the restricted dataset could aﬀ ect the 
generalisability of some of our data, this limitation 
would have been present in many other communities in 
sub-Saharan Africa, and, in view of the similarity in age 
and sex distribution of those who had blood samples 
taken and those who did not, any resulting bias is likely 
to be small. Results for the individuals in whom HIV 
test results were borderline positive and insuﬃ  cient 
blood remained to repeat the test are presented as 
analysed. We have no reason to believe that this method 
could have resulted in systematic bias. All tests that 
were repeated conﬁ rmed the original test result. 
Although cholesterol concentrations can vary after 
stroke, we noted no signiﬁ cant diﬀ erence in ratio of 
total cholesterol to HDL cholesterol levels between 
those seen within 28 days of stroke and those not. This 
minor variability in cholesterol concentrations after 
stroke has been noted by other investigators.33 We 
treated all missing values as being missing completely 
at random. We could have used methods of imputation; 
however, this technique would have skewed our data 
unnecessarily and the most pragmatic approach was to 
present the raw data as collected.
Finally, we acknowledge that our ﬁ ndings are based on 
patients who survived long enough to be identiﬁ ed, 
interviewed, and assessed by the TSIP investigators, and 
that those identiﬁ ed only after death (by verbal autopsy) 
might have had a diﬀ erent cause of stroke, and thus a 
diﬀ erent risk-factor proﬁ le. Only with identiﬁ cation of a 
large community-based cohort, and with follow-up to see 
which individuals went on to have a stroke, could 
information about those who died rapidly after stroke be 
obtained. Such a study is likely to prove logistically 
diﬃ  cult in a setting such as sub-Saharan Africa where 
migration into, out of, and within communities is often 
undocumented.
Our study identiﬁ ed many of the risk factors for stroke 
already shown for other world regions. Despite the 
acknowledged limitations of our study, our data for HIV 
status are unique, especially in view of the fact that all 
participants were antiretroviral therapy naive. Our study 
provides evidence of a link between HIV infection and 
stroke in the absence of secondary complications due to 
the side-eﬀ ects of medication.
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Panel: Research in context
Systematic review
We did not do a speciﬁ c systematic review of the scientiﬁ c literature before undertaking 
this study. However, our study team was aware of the extremely scarce previous data for 
stroke risk factors in sub-Saharan Africa; therefore, a formal systematic review would be 
unlikely to yield any additional insight. On the basis of the existing literature, and of 
ﬁ ndings from previous studies done by members of our study team,5,19–21 we recognised 
that an important unanswered question was: what are the risk factors for stroke in 
sub-Saharan Africa? RW has conducted previous research on stroke in Tanzania, from 
which key ﬁ ndings have been published.5,19
Interpretation
Our study adds substantially to the existing knowledge of stroke risk factors in sub-Saharan 
Africa. This report is the ﬁ rst published community-based, case-control study of HIV 
infection as a risk factor for stroke with prospective case-ascertainment. The role of the risk 
factors investigated seems to be similar to those reported in other world regions. Our data 
for the role of HIV infection are unique and provide new insight into the interplay between 
two medical problems that are a major burden on health-care services in the region. 
Clinicians should be aware of the increased risk of stroke in people with HIV, even in the 
absence of antiretroviral treatment. 
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